Winthrop University   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Rock Hill SC United States (1886)

Organization Overview

First Clinical Trial
2004
NCT00327847
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Department of Nephrology, Winthrop Univ Hospital | Mark Davis-Lorton, MD | Winthrop University | Winthrop University Hospital | Winthrop University Hospital Department of Urology | Winthrop University Hospital, Outpatient Dialysis | Winthrop-Unviersity Hospital

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acute Coronary Syndrome (Phase 2)

Aggression (Phase 4)

Alzheimer Disease (Phase 4)

Angioedema (Phase 2)

Angioedemas, Hereditary (Phase 2)

Atrophy (Phase 1)

Bone Diseases (Phase 4)

Clostridium Infections (Phase 3)

Hemorrhage (Phase 4)

Hereditary Angioedema Types I and II (Phase 2)

Hypercalcemia (Phase 4)

Hyperparathyroidism (Phase 4)

Hyperparathyroidism, Secondary (Phase 4)

Hyperphosphatemia (Phase 4)

Inflammation (Phase 4)

Kidney Failure, Chronic (Phase 4)

Multiple Sclerosis (Phase 2)

Muscular Atrophy (Phase 1)

Muscular Atrophy, Spinal (Phase 1)

Osteoporosis (Phase 3)

Pancreatitis (Phase 2)

Pancreatitis, Chronic (Phase 2)

Prader-Willi Syndrome (Phase 4)

Prostatic Neoplasms (Phase 2)

Pruritus (Phase 4)

Renal Insufficiency (Phase 4)

Sclerosis (Phase 2)

Self-Injurious Behavior (Phase 4)

Syndrome (Phase 4)

Weight Gain (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 27
  • # of Trial APIs: 22